Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes
Serum levels of tumor necrosis factor-α (TNF-α) are usually elevated in patients with new-onset of overt type 1 diabetes. While Golimumab, a human monoclonal...
Category: Diabetes
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
Finerenone is a nonsteroidal, selective mineralocorticoid receptor antagonist. The short-term use of Finerenone, in patients with chronic kidney disease (CKD) and type 2 diabetes,...
Compression Therapy to Prevent Recurrent Cellulitis of the Leg
Compression therapy is a treatment involved in wearing compression garment daily. Guidelines suggest that this therapy can prevent the recurrence of cellulitis in patients...
Efficacy and Usability of Intranasal Glucagon for the Management of Hypoglycemia in Patients with Diabetes: A Systematic Review
Albeit, in unconscious patients with severe hypoglycemia, treatment with injectable glucagon is recommended. There are limitations to the use of this formulation. Hence, the...
Comparative effectiveness of gliclazide modified-release versus sitagliptin as second-line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes
Sulfonylureas (SUs) and dipeptidyl peptidase-4 (DPP-4) inhibitors are available for second-line treatment after metformin in type 2 diabetes mellitus (T2D). Gliclazide modified release (MR)...
Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment
Research has shown that type 2 diabetics prefer fewer injections. Insulin icodec is developed to treat patients with diabetes. Icodec insulin has a half-life...
